Literature DB >> 12611391

Cytokine mediation of experimental heart failure-induced anhedonia.

Angela J Grippo1, Joseph Francis, Robert M Weiss, Robert B Felder, Alan Kim Johnson.   

Abstract

Immune system dysfunction is hypothesized to influence several disease states, including cardiovascular disease and psychological depression. The comorbidity of depression and coronary artery disease may be influenced by immune system-brain interactions involving proinflammatory cytokines. The present studies evaluated an index of depression in a rodent model of heart failure by measuring responses to rewarding electrical brain stimulation, which provides an experimental procedure to operationally define anhedonia in rats. Heart failure led to a rightward shift in the current-response relationship in the brain stimulation paradigm, indicative of reduced rewarding properties of the brain stimulation (i.e., anhedonia). Acute treatment with a tumor necrosis factor antagonist, etanercept, reduced circulating tumor necrosis factor- levels in rats with heart failure and restored responding for electrical brain stimulation. The current findings have implications for the study of pathophysiological mechanisms underlying the association of cardiovascular disease and depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12611391     DOI: 10.1152/ajpregu.00430.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  22 in total

1.  The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health.

Authors:  Angela J Grippo
Journal:  Soc Personal Psychol Compass       Date:  2011-04

2.  Identification and treatment of symptoms associated with inflammation in medically ill patients.

Authors:  Robert Dantzer; Lucile Capuron; Michael R Irwin; Andrew H Miller; Helene Ollat; Victor Hugh Perry; Sarah Rousey; Raz Yirmiya
Journal:  Psychoneuroendocrinology       Date:  2007-12-03       Impact factor: 4.905

3.  Social isolation disrupts autonomic regulation of the heart and influences negative affective behaviors.

Authors:  Angela J Grippo; Damon G Lamb; C Sue Carter; Stephen W Porges
Journal:  Biol Psychiatry       Date:  2007-07-20       Impact factor: 13.382

Review 4.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 5.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 6.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

7.  Effects of octreotide in chronically mild stressed rats: possible role of immune and oxidative stress pathways.

Authors:  Mona F Schaalan; Noha N Nassar
Journal:  Neurochem Res       Date:  2011-05-21       Impact factor: 3.996

8.  Behavioral cross-sensitization between DOCA-induced sodium appetite and cocaine-induced locomotor behavior.

Authors:  Martin J Acerbo; Alan Kim Johnson
Journal:  Pharmacol Biochem Behav       Date:  2011-02-22       Impact factor: 3.533

Review 9.  Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Wei Wang; Lie Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

10.  Estradiol modulates anhedonia and behavioral despair in rats and negative affect in a subgroup of women at high risk for postpartum depression.

Authors:  Crystal Edler Schiller; Michael W O'Hara; David R Rubinow; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.